Sort
21,281 grants matching “influenza”
Methods for Evaluating Vaccine Efficacy
$528,251M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · R37 · FY2010 · AI
Molecular Mechanisms and In Vivo Impact of Tethered Mucin 1-Influenza Virus Interactions
$528,165Margaret Adele Scull · Univ Of Maryland, College Park · R01 · FY2024 · HL
Animal Models Core
$528,159Fernando Pardo-Manuel De Villena · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Balancing Airway Progenitor versus Progeny: a Pathway from Mitochondria
$528,047Xin Sun · University Of California, San Diego · R01 · FY2021 · HL
Transcriptional Regulation of Antibody Responses and Immunity
$528,044Deepta Bhattacharya · University Of Arizona · R01 · FY2024 · AI
Age related loss of immune resilience during response to severe respiratory viral infections
$528,011Leopoldo Nicolas Segal · New York University School Of Medicine · U01 · FY2024 · AG
A 3D human tissue-engineered lung model to study immune responses to Respiratory Syncytial Virus
$527,856Susan Kovats · Oklahoma Medical Research Foundation · R01 · FY2019 · EB
Structure, Mechanism and Regulation of the V-ATPases
$527,838Michael D Forgac · Tufts University Boston · R37 · FY2006 · GM
Clock Gene Control of Viral Infection and Asthma
$527,404Jeffrey Adam Haspel · Washington University · R01 · FY2021 · HL
NIH Director's Pioneer Award: Antigenic Cartography
$527,310Derek James Smith · University Of Cambridge · DP1 · FY2009 · OD
NIH Director's Pioneer Award: Antigenic Cartography
$527,310Derek James Smith · University Of Cambridge · DP1 · FY2007 · OD
NIH Director's Pioneer Award: Antigenic Cartography
$527,310Derek James Smith · University Of Cambridge · DP1 · FY2008 · OD
RETINA: REVERSED POLARITY AND MORPHOGENESIS OF RPE
$527,238Weill Medical College Of Cornell Univ · R01 · FY2005 · EY
MALARIA VACCINE--ATTENUATED INFLUENZA &VACCINIA VECTORS
$527,059New York University School Of Medicine · R01 · FY2001 · AI
Novel broad spectrum vaccination against influenza
$526,994Curelab, Inc. · R43 · FY2005 · AI
Generation of antigen-specific regulation T cells
$526,785Dana-Farber Cancer Institute · R37 · FY2003 · AI
Topology, Antigenicity, and Immunogenicity of the C-terminal Tail (CTT) of HIV-1
$526,740Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AI
Combining innovative molecular adjuvanting approaches with novel adenoviral vector delivery to generate a universal influenza vaccine
$526,601Lynda Coughlan · University Of Maryland Baltimore · R01 · FY2022 · AI
Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination
$526,550Sara Lustigman · New York Blood Center · U01 · FY2020 · AI
Boosting Flu Vaccination without Adjuvant Injection
$526,515Mei X Wu · Massachusetts General Hospital · R01 · FY2011 · AI
METHODS FOR EVALUATING VACCINE EFFICACY
$526,498Emory University · R01 · FY2002 · AI
Vaccine and Treatment Evaluation Units
$526,460Robert B. Belshe · Saint Louis University · N01 · FY2011 · AI
Personalized relapse prediction in Alcohol Use Disorder
$526,411Anna Zilverstand · University Of Minnesota · R01 · FY2023 · AA
Molecular Mechanisms of Influenza Pandemics
$526,358University Of Wisconsin Madison · R01 · FY2004 · AI
Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model
$526,307Florence Nicolas · Osivax Sas · R01 · FY2024 · AI